X Trademark

Trademark Overview


On Wednesday, November 23, 2016, a trademark application was filed for X with the United States Patent and Trademark Office. The USPTO has given the X trademark a serial number of 87246438. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 17, 2025. This trademark is owned by Axcella Health Inc.. The X trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and agents for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the g...
x

General Information


Serial Number87246438
Word MarkX
Filing DateWednesday, November 23, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 17, 2025
Registration Number5716055
Registration DateTuesday, April 2, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations and agents for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medicines, namely, proteins, biomolecules in the nature of polypeptides and peptides, amino acids and small molecules in the nature of organic compounds and amino acid metabolites for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medical foods, namely, dietetic food that is intended for the specific dietary management of a disease or condition; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; dietary and nutritional supplements
Description of MarkThe mark consists of a stylized "X" consisting of two trapezoids and four triangles with the trapezoids comprising the upper legs of the "X", two triangles pointing outward comprising the middle and two triangles pointing inward comprising the lower legs.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 17, 2025
Primary Code005
First Use Anywhere DateMonday, January 7, 2019
First Use In Commerce DateMonday, January 7, 2019

Trademark Owner History


Party NameAXCELLA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSANTA CLARA, CA 95054

Party NameAxcella Health Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameAxcella Health Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameAxcella Health Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Saturday, November 26, 2016NEW APPLICATION ENTERED
Thursday, December 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 2, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 15, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2017ASSIGNED TO EXAMINER
Wednesday, March 1, 2017NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2017NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 9, 2017TEAS PETITION TO REVIVE RECEIVED
Saturday, September 9, 2017PETITION TO REVIVE-GRANTED
Saturday, September 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 11, 2017NOTICE OF REVIVAL - E-MAILED
Sunday, September 17, 2017ASSIGNED TO LIE
Tuesday, September 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 20, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 21, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, September 21, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, September 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 21, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, September 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 19, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, June 19, 2018SOU EXTENSION 1 FILED
Tuesday, June 19, 2018SOU EXTENSION 1 GRANTED
Thursday, June 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 10, 2018ASSIGNED TO EXAMINER
Friday, December 7, 2018SOU TEAS EXTENSION RECEIVED
Friday, December 7, 2018SOU EXTENSION 2 FILED
Friday, December 7, 2018SOU EXTENSION 2 GRANTED
Tuesday, December 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 5, 2019TEAS STATEMENT OF USE RECEIVED
Sunday, February 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 5, 2019USE AMENDMENT FILED
Sunday, February 24, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 27, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 28, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 15, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 17, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 17, 2025CANCELLED SEC. 8 (6-YR)